Login with ORCID

association

Full identifier: http://purl.org/np/RAMhWTdQYm7-1lRytMlNJqguHNghQGKpNDZKTE44FkWNg#association

Assigned to 1 class:

Minted in Nanopublication

 RAMhWTdQYm comment approve/disapprove edit as derived nanopublication create new with same template

This is the identifier for this whole nanopublication. http://purl.org/np/RAMhWTdQYm... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal)
(xsd:dateTime)
.
This is the identifier for this whole nanopublication. http://purl.org/np/RAMhWTdQYm... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAhNHZw6Ur...
.
This is the identifier for this whole nanopublication. http://purl.org/np/RAMhWTdQYm... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW...
.
This is the identifier for this whole nanopublication. http://purl.org/np/RAMhWTdQYm... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC...
.

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:53:02.725Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
"ELLENCE is contraindicated in patients with: Severe myocardial insufficiency [see Warnings and Precautions (5.1) Recent myocardial infarction or severe arrhythmias, or previous treatment with maximum cumulative dose of anthracyclines [see Warnings and Precautions (5.1) Severe persistent drug-induced myelosuppression [see Warnings and Precautions (5.4) Severe hepatic impairment (defined as Child-Pugh Class C or serum bilirubin level greater than 5 mg/dL) [see Warnings and Precautions (5.5) Severe hypersensitivity to ELLENCE, other anthracyclines, or anthracenediones [see Adverse Reactions (6.1) Severe myocardial insufficiency ( 4 Recent myocardial infarction ( 4 Severe persistent drug-induced myelosuppression ( 4 Severe hepatic impairment ( 4 Severe hypersensitivity to ELLENCE, other anthracyclines, or anthracenediones ( 4"
Leoni Bücken
2021-08-25T11:53:02.725Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:53:02.725Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:53:02.725Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:53:02.725Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:53:02.725Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-25T11:53:02.725Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)